Lalach Harvey 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Mar 14, 2011
Insider Transaction Report
Form 4
Lalach Harvey
DirectorPresident CEO CFO
Transactions
- Sale
common stock
2011-03-10$3.68/sh−5,500$20,240→ 589,872 total
Holdings
- 595,372
common stock
- 200,000
stock options
Exercise: $3.50From: 2010-06-29Exp: 2015-06-29→ common stock (50,000 underlying) - 150,000
stock options
Exercise: $3.10From: 2008-06-03Exp: 2013-06-03→ common stock (150,000 underlying)